Daniel DeOliveira, PhDVice President, Drug Substance Development and Manufacturing at Kailera TherapeuticsSpeaker
Agenda Sessions
Chairman’s Remarks: Targeted Peptide Radiopharmaceuticals
, 8:25amView SessionAdvancing Next-Generation Therapies for Obesity and Related Conditions
, 2:30pmView Session